Lung cancer targeted drugs can usually be considered to be taken one month after surgery, and genetic testing is needed before taking targeted drugs. It should not be taken without authorization and should follow the doctor’s instruction.
Patients with lung cancer need to undergo genetic testing before taking targeted drugs to confirm that there are gene mutation sites before they can take targeted drugs. The therapeutic principle of targeted drugs is mainly to take advantage of the molecular biology differences between malignant tumor cells and normal tissue cells, and act on specific structures or receptors, etc., so as to inhibit the growth of malignant tumor cells.
After lung malignant tumor surgery, the patient’s body is generally weak, it is recommended to wait until the patient’s body recovers about one month after surgery before considering taking targeted drugs for treatment. Patients with lung malignant tumors can choose gefitinib, amitinib and so on.
When patients with lung malignant tumors need to take targeted drugs orally, it is recommended to consult oncologists in regular hospitals and not to take them without authorization.